Safety and tolerability of pasireotide long-acting release in acromegaly—results from the acromegaly, open-label, multicenter, safety monitoring program for treating patients who have a need to receive medical therapy (ACCESS) study-Reference-Cited by-同舟云学术

Safety and tolerability of pasireotide long-acting release in acromegaly—results from the acromegaly, open-label, multicenter, safety monitoring program for treating patients who have a need to receive medical therapy (ACCESS) study

Published:2016-11-28 Issue:1 Volume:55 Page:247-255
ISSN:1355-008X
Container-title:Endocrine
language:en
Short-container-title:Endocrine

Author:

Fleseriu Maria, ,Rusch Elisha,Geer Eliza B.

Funder

Novartis Pharmaceuticals Corporation

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/content/pdf/10.1007/s12020-016-1182-4.pdf

Reference33 articles.

1. L. Katznelson, Drug insight: primary medical therapy of acromegaly. Nat. Clin. Pract. Endocrinol. Metab. 2(2), 109–117 (2006); quiz following 117

2. L. Katznelson, J.L.D. Atkinson, D.M. Cook, S.Z. Ezzat, A.H. Hamrahian, K.K. Miller, American association of clinical endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of acromegaly—2011 update. Endocr. Pract. 17(Suppl 4), 1–44 (2011)

3. L. Katznelson, E.R. Laws Jr., S. Melmed, M.E. Molitch, M.H. Murad, A. Utz, J.A.H. Wass, Acromegaly: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 99(11), 3933–3951 (2014)

4. S. Melmed, Acromegaly pathogenesis and treatment. J. Clin. Invest. 119(11), 3189–3202 (2009)

5. S. Melmed, F.F. Casanueva, A. Klibanski, M.D. Bronstein, P. Chanson, S.W. Lamberts, C.J. Strasburger, J.A.H. Wass, A. Giustina, A consensus on the diagnosis and treatment of acromegaly complications. Pituitary 16(3), 294–302 (2013)

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Pasireotide Treatment in Acromegaly: A Systematic Review and Single Arm Meta-Analysis;2024-08-27

2. Management of Diabetes Mellitus in Acromegaly and Cushing’s Disease with Focus on Pasireotide Therapy: A Narrative Review;Diabetes, Metabolic Syndrome and Obesity;2024-07

3. Current role of pasireotide in the treatment of acromegaly;Best Practice & Research Clinical Endocrinology & Metabolism;2024-07

4. Long-term pasireotide therapy in acromegaly: extensive real-life experience of a referral center;Journal of Endocrinological Investigation;2024-03-26

5. Real-life data of Pasireotide LAR in acromegaly: a long-term follow-up;Journal of Endocrinological Investigation;2024-01-20